Effect-directed screening of Bacillus lipopeptide extracts via hyphenated high-performance thin-layer chromatography.
Aliivibrio fischeri
/ metabolism
Anti-Bacterial Agents
/ pharmacology
Bacillus
/ metabolism
Bacillus subtilis
/ drug effects
Biological Assay
Chromatography, Thin Layer
/ methods
Lipopeptides
/ analysis
Mass Spectrometry
Ninhydrin
/ chemistry
Peptides, Cyclic
/ chemistry
Plant Extracts
/ chemistry
Pyridines
/ chemistry
Bacillus spp.
Biocontrol strains
Direct bioautography
HPTLC-acetylcholinesterase assay
HPTLC-α-glucosidase assay
Lipopeptides
Journal
Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488
Informations de publication
Date de publication:
08 Nov 2019
08 Nov 2019
Historique:
received:
05
05
2019
revised:
10
07
2019
accepted:
12
07
2019
pubmed:
6
8
2019
medline:
17
1
2020
entrez:
6
8
2019
Statut:
ppublish
Résumé
Bacillus species produce a wide array of biologically active metabolites, including nonribosomaly synthesized lipopeptides (LPs). The high-performance thin-layer chromatography (HPTLC) technique hyphenated with different bioassays and mass spectrometry was demonstrated as a valuable tool for effect-directed analysis of iturins, surfactins, fengycins and kurstakins homologues from complex mixtures of LPs. As proof of this straightforward strategy, the found surfactin and iturin A homologues were characterized and compared with reference substances. This study considered two different extraction methods for LPs produced by five Bacillus strains. The ethyl acetate extraction (Ex-1), and the acidic precipitation followed by methanol extraction (Ex-2) were investigated. Diverse enzyme inhibitions and antimicrobial potentials of LPs were analyzed, and in parallel, high-resolution mass spectra (HRMS) were online recorded from the HPTLC zones of interest. No antimicrobial effect against Gram-positive B. subtilis was evident for iturin, whereas a response was detected for surfactin. The nonpolar kurstakin compounds showed a pronounced B. subtilis antimicrobial activity in Ex-1 of almost all strains, whereas the fengycin homologues were detected in Ex-2 of SS-10.7 and SS-27.2. Iturin had also no activity against Gram-negative Aliivibrio fischeri, while again surfactin showed an enhancing luminescent activity. Contrary, kurstakin compounds caused a decrease in the luminescence in Ex-1 of all strains, particularly for SS-13.1. Both, iturin and surfactin showed a strong acetylcholinesterase (AChE) and α-glucosidase inhibition, but surfactin caused a much stronger inhibition. This was evident in all bacterial strains, except for SS-13.1 in Ex-1 and for SS-38.4 in Ex-2. Although, iturin and surfactin exhibited no DPPH˙ scavenging activity, Ex-1 of all strains contained more intense DPPH˙ scavenging compounds compared to Ex-2, and surfactin methyl esters showed a pronounced DPPH˙ activity, particularly in SS-12.6 in Ex-1. This study pointed to active metabolites of strains that can be used as therapeutics and biocontrol agents with beneficial effects on human health. The straightforward HPTLC profiling served as an excellent bioanalytical tool to control the formed bioactive metabolites. As the fermentation process is very sensitive to external influences, it could be a helpful control tool for standardization of the biotechnological processing.
Identifiants
pubmed: 31378526
pii: S0021-9673(19)30750-2
doi: 10.1016/j.chroma.2019.460366
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Lipopeptides
0
Peptides, Cyclic
0
Plant Extracts
0
Pyridines
0
fengycin
102577-03-7
iturin A
52229-90-0
gamma-collidine
7IE4BK5J5V
Ninhydrin
HCL6S9K23A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
460366Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.